vs
CORCEPT THERAPEUTICS INC（CORT）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是CORCEPT THERAPEUTICS INC的1.6倍（$324.4M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 5.7%，领先6.3%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 10.4%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $-13.3M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 9.5%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
CORT vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.6倍
$202.1M
营收增速更快
CORT
高出0.7%
10.4%
净利率更高
CORT
高出6.3%
5.7%
自由现金流更多
CORT
多$51.7M
$-13.3M
两年增速更快
CORT
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $324.4M |
| 净利润 | $24.3M | $18.6M |
| 毛利率 | 98.7% | 53.3% |
| 营业利润率 | 2.2% | 6.3% |
| 净利率 | 12.0% | 5.7% |
| 营收同比 | 11.1% | 10.4% |
| 净利润同比 | -21.0% | 50.4% |
| 每股收益（稀释后） | $0.20 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTRVLV
| Q4 25 | $202.1M | $324.4M | ||
| Q3 25 | $207.6M | $295.6M | ||
| Q2 25 | $194.4M | $309.0M | ||
| Q1 25 | $157.2M | $296.7M | ||
| Q4 24 | $181.9M | $293.7M | ||
| Q3 24 | $182.5M | $283.1M | ||
| Q2 24 | $163.8M | $282.5M | ||
| Q1 24 | $146.8M | $270.6M |
净利润CORTRVLV
| Q4 25 | $24.3M | $18.6M | ||
| Q3 25 | $19.7M | $21.2M | ||
| Q2 25 | $35.1M | $10.2M | ||
| Q1 25 | $20.5M | $11.8M | ||
| Q4 24 | $30.7M | $12.3M | ||
| Q3 24 | $47.2M | $11.0M | ||
| Q2 24 | $35.5M | $15.4M | ||
| Q1 24 | $27.8M | $10.9M |
毛利率CORTRVLV
| Q4 25 | 98.7% | 53.3% | ||
| Q3 25 | 97.8% | 54.6% | ||
| Q2 25 | 98.2% | 54.1% | ||
| Q1 25 | 98.5% | 52.0% | ||
| Q4 24 | 98.4% | 52.5% | ||
| Q3 24 | 98.4% | 51.2% | ||
| Q2 24 | 98.5% | 54.0% | ||
| Q1 24 | 98.3% | 52.3% |
营业利润率CORTRVLV
| Q4 25 | 2.2% | 6.3% | ||
| Q3 25 | 4.9% | 7.1% | ||
| Q2 25 | 13.7% | 5.8% | ||
| Q1 25 | 2.2% | 5.0% | ||
| Q4 24 | 13.9% | 3.9% | ||
| Q3 24 | 25.5% | 5.0% | ||
| Q2 24 | 21.7% | 5.8% | ||
| Q1 24 | 20.1% | 3.4% |
净利率CORTRVLV
| Q4 25 | 12.0% | 5.7% | ||
| Q3 25 | 9.5% | 7.2% | ||
| Q2 25 | 18.1% | 3.3% | ||
| Q1 25 | 13.1% | 4.0% | ||
| Q4 24 | 16.9% | 4.2% | ||
| Q3 24 | 25.9% | 3.9% | ||
| Q2 24 | 21.7% | 5.4% | ||
| Q1 24 | 18.9% | 4.0% |
每股收益（稀释后）CORTRVLV
| Q4 25 | $0.20 | $0.27 | ||
| Q3 25 | $0.16 | $0.29 | ||
| Q2 25 | $0.29 | $0.14 | ||
| Q1 25 | $0.17 | $0.16 | ||
| Q4 24 | $0.25 | $0.18 | ||
| Q3 24 | $0.41 | $0.15 | ||
| Q2 24 | $0.32 | $0.21 | ||
| Q1 24 | $0.25 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $512.5M |
| 总资产 | $836.7M | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTRVLV
| Q4 25 | $372.2M | $292.3M | ||
| Q3 25 | $421.7M | $315.4M | ||
| Q2 25 | $342.2M | $310.7M | ||
| Q1 25 | $322.8M | $300.8M | ||
| Q4 24 | $383.3M | $256.6M | ||
| Q3 24 | $380.3M | $252.8M | ||
| Q2 24 | $473.2M | $244.7M | ||
| Q1 24 | $410.8M | $273.4M |
股东权益CORTRVLV
| Q4 25 | $647.8M | $512.5M | ||
| Q3 25 | $631.9M | $490.2M | ||
| Q2 25 | $635.8M | $468.6M | ||
| Q1 25 | $683.3M | $453.4M | ||
| Q4 24 | $679.6M | $437.8M | ||
| Q3 24 | $638.8M | $420.8M | ||
| Q2 24 | $596.2M | $405.8M | ||
| Q1 24 | $547.9M | $389.9M |
总资产CORTRVLV
| Q4 25 | $836.7M | $765.0M | ||
| Q3 25 | $823.6M | $751.3M | ||
| Q2 25 | $801.7M | $722.9M | ||
| Q1 25 | $846.5M | $713.9M | ||
| Q4 24 | $840.6M | $665.5M | ||
| Q3 24 | $784.3M | $670.9M | ||
| Q2 24 | $714.6M | $657.8M | ||
| Q1 24 | $655.9M | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $-13.3M |
| 自由现金流率自由现金流/营收 | 19.0% | -4.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.0% |
| 现金转化率经营现金流/净利润 | 1.58× | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流CORTRVLV
| Q4 25 | $38.4M | $-10.2M | ||
| Q3 25 | $54.5M | $11.8M | ||
| Q2 25 | $43.9M | $12.6M | ||
| Q1 25 | $5.1M | $45.1M | ||
| Q4 24 | $59.3M | $3.9M | ||
| Q3 24 | $73.8M | $9.1M | ||
| Q2 24 | $41.2M | $-24.7M | ||
| Q1 24 | $23.8M | $38.4M |
自由现金流CORTRVLV
| Q4 25 | $38.4M | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | $43.9M | $10.4M | ||
| Q1 25 | $5.0M | $43.4M | ||
| Q4 24 | $59.2M | $2.1M | ||
| Q3 24 | $72.2M | $8.0M | ||
| Q2 24 | $40.8M | $-25.7M | ||
| Q1 24 | — | $36.7M |
自由现金流率CORTRVLV
| Q4 25 | 19.0% | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 22.6% | 3.4% | ||
| Q1 25 | 3.2% | 14.6% | ||
| Q4 24 | 32.5% | 0.7% | ||
| Q3 24 | 39.5% | 2.8% | ||
| Q2 24 | 24.9% | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度CORTRVLV
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.9% | 0.4% | ||
| Q2 24 | 0.3% | 0.4% | ||
| Q1 24 | 0.0% | 0.6% |
现金转化率CORTRVLV
| Q4 25 | 1.58× | -0.55× | ||
| Q3 25 | 2.77× | 0.56× | ||
| Q2 25 | 1.25× | 1.24× | ||
| Q1 25 | 0.25× | 3.82× | ||
| Q4 24 | 1.93× | 0.32× | ||
| Q3 24 | 1.56× | 0.83× | ||
| Q2 24 | 1.16× | -1.60× | ||
| Q1 24 | 0.86× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
